Systemic delivery of MicroRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice

Circulation Research

Volumn 114, Issue 1, 2014, Pages 32-40

  Sun, Xinghui ^a   He, Shaolin ^a,b   Wara, A K M ^a   Icli, Basak ^a   Shvartz, Eugenia ^a   Tesmenitsky, Yevgenia ^a   Belkin, Nathan ^a   Li, Dazhu ^b   Blackwell, Timothy S ^c   Sukhova, Galina K ^a   Croce, Kevin ^a   Feinberg, Mark W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; endothelial cells; inflammation; karyopherins; microRNAs; NF B

Indexed keywords

APOLIPOPROTEIN E; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; KARYOPHERIN ALPHA; MICRORNA; MICRORNA 146A; MICRORNA 181B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA INTIMA; ARTICLE; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VASCULITIS;

EID: 84892908098     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.113.302089     Document Type: Article

References (46)

1. Libby P. Infammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:2045-2051.
2. Libby P. Infammation in atherosclerosis. Nature. 2002;420:868-874.
3. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL. ApoE-defcient mice are a model of lipoprotein oxidation in atherogen-esis. Demonstration of oxidation-specifc epitopes in lesions and high ti-ters of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb. 1994;14:605-616.
4. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035-2038.
5. Hernández-Presa M, Bustos C, Ortego M, Tuñon J, Renedo G, Ruiz-Ortega M, Egido J. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant pro-tein-1 expression, and macrophage infltration in a rabbit model of early accelerated atherosclerosis. Circulation. 1997;95:1532-1541.
6. Hajra L, Evans AI, Chen M, Hyduk SJ, Collins T, Cybulsky MI. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci USA. 2000;97:9052-9057.
7. Davies PF, Polacek DC, Handen JS, Helmke BP, DePaola N. A spatial approach to transcriptional profling: mechanotransduction and the focal origin of atherosclerosis. Trends Biotechnol. 1999;17:347-351.
8. Baker RG, Hayden MS, Ghosh S. NF-κB, infammation, and metabolic disease. Cell Metab. 2011;13:11-22.
9. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. Control of I kappa B-alpha proteolysis by site-specifc, signal-induced phosphoryla-tion. Science. 1995;267:1485-1488.
10. Chen ZJ, Parent L, Maniatis T. Site-specifc phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell. 1996;84:853-862.
11. de Winther MP, Kanters E, Kraal G, Hofker MH. Nuclear factor kap-paB signaling in atherogenesis. Arterioscler Thromb Vasc Biol. 2005;25:904-914.
12. Kempe S, Kestler H, Lasar A, Wirth T. NF-kappaB controls the global pro-infammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program. Nucleic Acids Res. 2005;33:5308-5319.
13. Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJ, Kardakaris R, Polykratis A, Kollias G, de Winther MP, Pasparakis M. Endothelial cell-specifc NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab. 2008;8:372-383.
14. Bourdillon MC, Poston RN, Covacho C, Chignier E, Bricca G, McGregor JL. ICAM-1 defciency reduces atherosclerotic lesions in double-knockout mice (ApoE(-/-)/ICAM-1(-/-)) fed a fat or a chow diet. Arterioscler Thromb Vasc Biol. 2000;20:2630-2635.
15. Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO, Wagner DD. The combined role of P-and E-selectins in atherosclerosis. J Clin Invest. 1998;102:145-152.
16. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS. A major role for vcam-1, but not icam-1, in early atherosclerosis. J ClinI Investig. 2001;107:1255-1262.
17. Brånén L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2004;24:2137-2142.
18. Merhi-Soussi F, Kwak BR, Magne D, Chadjichristos C, Berti M, Pelli G, James RW, Mach F, Gabay C. Interleukin-1 plays a major role in vascular infammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res. 2005;66:583-593.
19. Suárez Y, Wang C, Manes TD, Pober JS. Cutting edge: TNF-induced mi-croRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of in-fammation. J Immunol. 2010;184:21-25.
20. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA. 2008;105:1516-1521.
21. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinfammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci USA. 2010;107:13450-13455.
22. Cheng HS, Sivachandran N, Lau A, Boudreau E, Zhao JL, Baltimore D, Delgado-Olguin P, Cybulsky MI, Fish JE. MicroRNA-146 represses en-dothelial activation by inhibiting pro-infammatory pathways. EMBO Mol Med. 2013;5:949-966.
23. Sun X, Icli B, Wara AK, Belkin N, He S, Kobzik L, Hunninghake GM, Vera MP, Blackwell TS, Baron RM, Feinberg MW; MICU Registry. MicroRNA-181b regulates NF-κB-mediated vascular infammation. J Clin Invest. 2012;122:1973-1990.
24. Cui Y, Han Z, Hu Y, Song G, Hao C, Xia H, Ma X. MicroRNA-181b and microRNA-9 mediate arsenic-induced angiogenesis via NRP1. J Cell Physiol. 2012;227:772-783.
25. de Yébenes VG, Belver L, Pisano DG, González S, Villasante A, Croce C, He L, Ramiro AR. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J Exp Med. 2008;205:2199-2206.
26. Ebert PJ, Jiang S, Xie J, Li QJ, Davis MM. An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a. Nat Immunol. 2009;10:1162-1169.
27. Henao-Mejia J, Williams A, Goff LA, Staron M, Licona-Limon P, Kaech SM, Nakayama M, Rinn JL, Flavell RA. The microrna mir-181 is a critical cellular metabolic rheostat essential for nkt cell ontogenesis and lymphocyte development and homeostasis. Immunity. 2013;38:984-997.
28. Li G, Yu M, Lee WW, Tsang M, Krishnan E, Weyand CM, Goronzy JJ. Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med. 2012;18:1518-1524.
29. Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, Braich R, Manoharan M, Soutschek J, Skare P, Klein LO, Davis MM, Chen CZ. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007;129:147-161.
30. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epi-genetic switch linking infammation to cancer. Mol Cell. 2010;39:493-506.
31. Kazenwadel J, Michael MZ, Harvey NL. Prox1 expression is negatively regulated by miR-181 in endothelial cells. Blood. 2010;116:2395-2401.
32. Goossens P, Vergouwe MN, Gijbels MJ, Curfs DM, van Woezik JH, Hoeksema MA, Xanthoulea S, Leenen PJ, Rupec RA, Hofker MH, de Winther MP. Myeloid IκBα defciency promotes atherogenesis by enhancing leukocyte recruitment to the plaques. PLoS One. 2011;6:e22327.
33. Kanters E, Gijbels MJ, van der Made I, Vergouwe MN, Heeringa P, Kraal G, Hofker MH, de Winther MP. Hematopoietic NF-kappaB1 defciency results in small atherosclerotic lesions with an infammatory phenotype. Blood. 2004;103:934-940.
34. Kanters E, Pasparakis M, Gijbels MJ, Vergouwe MN, Partouns-Hendriks I, Fijneman RJ, Clausen BE, Förster I, Kockx MM, Rajewsky K, Kraal G, Hofker MH, de Winther MP. Inhibition of NF-kappaB activation in mac-rophages increases atherosclerosis in LDL receptor-defcient mice. J Clin Invest. 2003;112:1176-1185.
35. Park SH, Sui Y, Gizard F, Xu J, Rios-Pilier J, Helsley RN, Han SS, Zhou C. Myeloid-specifc IκB kinase β defciency decreases atherosclerosis in low-density lipoprotein receptor-defcient mice. Arterioscler Thromb Vasc Biol. 2012;32:2869-2876.
36. Polykratis A, van Loo G, Xanthoulea S, Hellmich M, Pasparakis M. Conditional targeting of tumor necrosis factor receptor-associated factor 6 reveals opposing functions of Toll-like receptor signaling in endothe-lial and myeloid cells in a mouse model of atherosclerosis. Circulation. 2012;126:1739-1751.
37. Fagerlund R, Melén K, Cao X, Julkunen I. NF-kappaB p52, RelB and c-Rel are transported into the nucleus via a subset of importin alpha molecules. Cell Signal. 2008;20:1442-1451.
38. Fagerlund R, Kinnunen L, Köhler M, Julkunen I, Melén K. NF-{kappa} B is transported into the nucleus by importin {alpha}3 and importin {al-pha}4. J Biol Chem. 2005;280:15942-15951.
39. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65:6029-6033.
40. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005;33:1290-1297.
41. Liu X, Cheng Y, Yang J, Xu L, Zhang C. Cell-specifc effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J Mol Cell Cardiol. 2012;52:245-255.
42. Köhler M, Ansieau S, Prehn S, Leutz A, Haller H, Hartmann E. Cloning of two novel human importin-alpha subunits and analysis of the expression pattern of the importin-alpha protein family. FEBS Lett. 1997;417:104-108.
43. Tergaonkar V, Perkins ND. p53 and NF-kappaB crosstalk: IKKalpha tips the balance. Mol Cell. 2007;26:158-159.
44. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007;8:49-62.
45. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-κB signaling pathways. Nat Immunol. 2011;12:695-708.
46. Ashida N, Senbanerjee S, Kodama S, Foo SY, Coggins M, Spencer JA, Zamiri P, Shen D, Li L, Sciuto T, Dvorak A, Gerszten RE, Lin C P, Karin M, Rosenzweig A. IKKβ regulates essential functions of the vascular endothe-lium through kinase-dependent and-independent pathways. Nat Commun. 2011;2:318.